The present study measured the expression levels of critical retinal ischemic or related inflammatory biomarkers, such as MCP-1, β-catenin, VEGF, and Ang-2, to gain insights into the mechanisms of action of catalpol against retinal ischemia. The gene discussed is CCL2; the disease is retinal ischemia.